Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-13

Clinical Trial Update: Motor Response to Sildenafil in PD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether sildenafil improves motor function in Parkinson's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Parkinsons Disease, Erectile Dysfunction | Phase 4 | Status: COMPLETED